Antibody Therapy for Patients with Lymphoid Malignancies: Past and Present

被引：0

作者：

Naman, Jacob ^{[1
]}

Shah, Nirja ^{[2
]}

Heyman, Benjamin M. ^{[3
]}

机构：

[1] UC San Diego Hlth, Dept Med, La Jolla, CA 92037 USA

[2] UCSD, Sch Med, La Jolla, CA 92037 USA

[3] UC San Diego Hlth, Div Regenerat Med, Dept Med, La Jolla, CA 92037 USA

来源：

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2025年 / 26卷 / 04期

关键词：

antibody; malignancy; CLL; FL; DLBCL; rituximab; obinutuzumab; polatuzumab; mosunetuzumab; epcoritamab; CHRONIC LYMPHOCYTIC-LEUKEMIA; ANTI-CD20; MONOCLONAL-ANTIBODY; PHASE-II TRIAL; MAGROLIMAB PLUS RITUXIMAB; LOW-TUMOR BURDEN; FOLLICULAR LYMPHOMA; OPEN-LABEL; LONCASTUXIMAB TESIRINE; BRENTUXIMAB VEDOTIN; 1ST-LINE TREATMENT;

D O I：

10.3390/ijms26041711

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Antibody therapies are a crucial component of modern lymphoid malignancy treatment and an exciting area of active research. We performed a review of modern antibody therapies used in the treatment of lymphoid malignancies, with an emphasis on landmark studies and current directions. We describe the indications for rituximab, obinutuzumab, ADCs, and bispecific antibody therapies. Finally, we summarize early data from ongoing trials on emerging novel therapy combination regimens and discuss the role of machine learning in future therapy development.

引用

页数：21

共 50 条

[1] Role of antibody therapy in lymphoid malignancies
Dearden, Claire E.
BRITISH MEDICAL BULLETIN, 2007, 83 (01) : 275 - 290
[2] Antibody-directed therapy: Past, present, and future
Gelfand, EW
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 108 (04) : S111 - S116
[3] TREATMENT OF MALIGNANCIES, PAST AND PRESENT
FREIREICH, EJ
HOSPITAL PRACTICE, 1993, 28 (03): : 109 - &
[4] γδ T cells for immune therapy of patients with lymphoid malignancies
Wilhelm, M
Kunzmann, V
Eckstein, S
Reimer, P
Weissinger, F
Ruediger, T
Tony, HP
BLOOD, 2003, 102 (01) : 200 - 206
[5] Reovirus therapy of lymphoid malignancies
Alain, T
Hirasawa, K
Pon, KJ
Nishikawa, SG
Urbanski, SJ
Auer, Y
Luider, J
Martin, A
Johnston, RN
Janowska-Wieczorek, A
Lee, PWK
Kossakowska, AE
BLOOD, 2002, 100 (12) : 4146 - 4153
[6] Pancreaticobiliary Malignancies: Past, Present, and Future
Herman, Joseph M.
SEMINARS IN RADIATION ONCOLOGY, 2014, 24 (02) : 61 - 66
[7] Development of venetoclax for therapy of lymphoid malignancies
Zhu, Huayuan
Almasan, Alexandru
DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 685 - 694
[8] Immunotherapy in hematologic malignancies: past, present, and future
Im, Annie
Pavletic, Steven Z.
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10
[9] Immunotherapy in hematologic malignancies: past, present, and future
Annie Im
Steven Z. Pavletic
Journal of Hematology & Oncology, 10
[10] Antibody therapy of lymphoid malignancies: Experience with CD52 (CAMPATH-1) antibodies
Dyer, MJS
EUROPEAN JOURNAL OF CANCER, 1997, 33 : 298 - 298

← 1 2 3 4 5 →